Aevitas Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$491K Buy
2021
Q2
$694K Buy
2021
Q1
$486K Buy
2020
Q4
$574K Buy
2019
Q2
Sell
2019
Q1
$82K Hold
2018
Q4
$66K Sell
2018
Q3
$169K Sell
2018
Q2
$518K Buy
2018
Q1
$313K Sell
2017
Q4
$671K Buy